Student's Tragic Death Linked to Hospital Hygiene Failures
A coroner has concluded that a "talented" 20-year-old student who previously beat cancer died from sepsis contracted due to "poor hospital hygiene" and cross-contamination at a specialist cancer facility.
From Cancer Recovery to Fatal Infection
Joshua Abbot-Littler from Wigan had triumphantly rung the "all clear" bell at The Christie Cancer Hospital in south Manchester in May 2024 after successful chemotherapy and proton beam therapy for Hodgkin lymphoma. The mathematics master's student at Lancaster University was described as "fit and well" following his recovery.
However, just one year later, Joshua was readmitted to hospital with flu-like symptoms including worsening chest pains, sore throat, tiredness and spontaneous bruising. He was initially treated at Royal Albert Edward Infirmary in Wigan before being transferred to The Christie.
Rare Secondary Cancer Diagnosis
Medical professionals diagnosed Joshua with treatment-induced acute myeloid leukaemia on June 8, 2025 - a rare, aggressive form of the disease triggered by previous cancer treatments like chemotherapy. This secondary cancer developed despite his successful battle against Hodgkin lymphoma.
The 20-year-old died in the early hours of June 26 from multiple organ failure caused by multidrug-resistant sepsis following a bacterial infection.
Coroner's Devastating Findings
At Manchester Coroners' Court, Coroner Andrew Bridgman described the circumstances as "one of the more tragic inquests" and "devastating" for Joshua's family. The investigation revealed that Joshua contracted the fatal infection through cross-contamination from another patient on the ward.
A Patient Safety Incident Investigation report confirmed that the strain of bacteria which caused Joshua's critical care admission matched that of another patient on the same ward. The report identified "inadequate adherence" to hand hygiene protocols and antiseptic techniques as the likely source of infection.
Infection Control Failures
The investigation specifically highlighted poor compliance with the aseptic non-touch technique (ANTT), designed to prevent microorganisms from entering patients' bodies through staff hands or contaminated surfaces. Joshua had a Peripherally Inserted Central Catheter inserted into his vein, which required strict ANTT protocols to prevent cross-contamination.
Coroner Bridgman concluded that while Joshua's death was initially linked to treatment-induced leukaemia, it was "overtaken by the inadequate adherence to antiseptic techniques." The Christie NHS Foundation Trust accepted responsibility for cross-contamination and lapses in infection control measures.
Hospital Response and Family Grief
A spokesperson for The Christie stated: "We offer our sincere condolences to Joshua's family. The safety of our patients is The Christie's highest priority. Following this incident, we have carried out a thorough review and have already implemented further improvements to strengthen our infection prevention practices."
Joshua's aunt, Rebecca Hughes, described her nephew as "intellectual" with diverse interests including chess and music. "He was a really clever boy who left school with straight nines," she said. "He was just a beautiful soul, a really lovely boy."
The family has been fundraising for Young Lives vs Cancer through a nine-hour walk from Wigan to Southport, finding purpose in their grief. They plan to commemorate what would have been Joshua's 21st birthday in January with further charitable activities.
Medical Details of the Case
In his final days, Joshua's condition deteriorated rapidly, with an echocardiogram showing his heart function severely impaired at 35 percent compared to the expected 55-60 percent. The official cause of death was recorded as multiple organ failure, multidrug-resistant sepsis from cross-contamination, and treatment-induced acute myeloid leukaemia.
Notably, the coroner confirmed that Joshua's original Hodgkin lymphoma did not directly cause his death. The tragedy highlights the critical importance of infection control protocols in healthcare settings, particularly for immunocompromised patients undergoing cancer treatment.
